<?xml version="1.0" encoding="UTF-8"?>
<p class="p">An important feature of the SFEE process is the ability to form nearly monodisperse microencapsulates or nanoencapsulates. 
 <xref rid="pharmaceutics-11-00021-t003" ref-type="table" class="xref">Table 3</xref> shows examples of microencapsulated and nanoencapsulated formulations produced using the SFEE process. Active ingredients ranging from low-bioavailability hydrophobic drugs [
 <xref rid="B66-pharmaceutics-11-00021" ref-type="bibr" class="xref">66</xref>,
 <xref rid="B67-pharmaceutics-11-00021" ref-type="bibr" class="xref">67</xref>,
 <xref rid="B68-pharmaceutics-11-00021" ref-type="bibr" class="xref">68</xref>] to model proteins [
 <xref rid="B69-pharmaceutics-11-00021" ref-type="bibr" class="xref">69</xref>] and even oils [
 <xref rid="B70-pharmaceutics-11-00021" ref-type="bibr" class="xref">70</xref>] can be encapsulated using this method.
</p>
